Next Hot Niche Asset Class?

In the past several years we have seen self-storage and manufactured housing communities/mobile home parks become more institutionalized. Life science properties and cold storage have also seen a large influx of capital over the past couple years. Now I am seeing a lot of institutional attention for industrial outdoor storage. What under the radar niche asset classes/sub property types do you think will be the next trend?

 

Not niche but life science assets in cities without a huge existing foot print. Boston/Cambridge is overly saturated but NY seems to be a couple years behind - we'll see if it takes hold. 

 

I have a guy I went to school with who works for QTS. They build data centers. Turnover is very low, most tenants who leave only do so because they need more data storage space. At the time there were only a handful of companies building them, not sure what it's like now. But they could build these in unique areas. Access to an electric grid was one of the main concerns. And according to him they would have 500 basis point spreads between return on costs and exit cap rate.

 

Seems like most of the big players (especially in Canada) got caught up with maximizing production capacity to increase their valuations in 2018 - 2020. Would definitely be interesting to see if they pivot to fewer and larger facilities to stem their losses!

 

cGMP - lots of biotech / pharma companies that are moving into Stage 2 / Stage 3 and need to start actually producing their products. Seems to be somewhat differentiated from life science / lab research spaces, still learning more about it.

 
Most Helpful

To piggyback on life science, another highly valuable niche is intellectual property in life sciences. Pharma giants will buy the IP of little biotech companies who have successfully created and shown efficacy of a new molecule to solve some health concern. From my limited understanding of working in this space, there seems to be a concentration in the acquisition of these little companies by the existing pharma giants because they know the space and have the personnel that know the disease state and science of the subject matter. I could see PE getting more involved here. I'm not sure what the exact ratio is but there is a known ratio that exists in the pharma world of when a drug passes a certain stage of the drug development process, there is a positive ratio in favor of the drug making it to market. Don't quote me but I believe it's passing stage 3. Now, this doesn't mean it will necessarily perform in the market and the pharma industry is highly competitive but there seems to be a heavy concentration by the existing giants to swallow up all of the promising new molecules that enter the market.

 

Personally think infrastructure will be huge in the years to come with investor thirst for yield and opportunities in energy transition while being defensive and recession-proof, especially core infra

 

very niche one, not saying it will be the next hot class, but just interesting and seeing it more and more. Outdoor Industrial Storage .... think industrial land / lots mostly for equipment / truck parking... but could be leased to CAT, Amazon etc. Little odd bc its usually shit land in shit nowhere but decent long term lease.. but JPM, AIG etc just raised large funds / are raising funds just for this class. 

 

Exercitationem corporis molestias quo fuga a. Fugit et enim laborum qui quibusdam fuga. Eaque nobis molestiae beatae optio alias est.

Culpa voluptatum aperiam consequatur aliquam. In eos repellendus tenetur laboriosam ipsum nulla. Minima quia impedit qui dolor consequatur placeat. Quisquam autem ut quidem excepturi. Sit eius autem voluptatem aperiam maiores. Est fuga temporibus sed quo aspernatur.

Ullam nihil dolorem quo voluptatum quasi eos velit. Saepe soluta molestiae deleniti culpa velit dolore dolore. Sed magnam quia veniam ea.

 

Mollitia quas quam suscipit tempore molestiae et. Tempore minus ut vitae reprehenderit accusantium vel. Error consequatur dolores facilis est. Enim et reprehenderit eaque nihil.

Impedit similique autem voluptas quam in ullam. Consequuntur mollitia beatae laboriosam a rem aut quia adipisci.

Doloribus iste eum voluptas itaque. Tempora molestiae enim sequi autem. Occaecati dolorem et beatae iusto ut. Aut iste velit non expedita dolorem quisquam.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”